FAIRFIELD, Conn. (January 15, 2020)—Convexity Scientific Incorporated (Convexity), provider of consumer-focused respiratory medical technology, announced at CES 2020 its purchase of the digital health assets of Wellinks Incorporated (Wellinks).
SAN DIEGO (November 15, 2019)—For COPD Awareness Month, ResMed has published an online repository containing educational materials on the condition for patients and health care professionals.
FAIRFIELD, Conn. (September 26, 2019)—Convexity Scientific, a medical technology company, announced this week the initial closing of a $3.5 million Series B financing. The round was led by HighCape Capital with participation from Connecticut Innovations, Benslie International, and Stonehenge Capital. The financing will help support commercial growth of the Convexity’s core product Flyp Nebulizer and adjacent innovations.
LONDON and PLANO, Texas (April 25, 2019)—Belluscura PLC announced that its crowdfunding campaign has exceeded the target raise of £500,000 ($647,000 USD). The campaign will remain open on Crowdcube (crowdcube.com) until May 3 to allow additional people the opportunity to invest in the company.
SAN DIEGO (January 8, 2019)—ResMed a provider of respiratory care medical devices and out-of-hospital care software, announced that its portable oxygen concentrator, Mobi, is now widely available in the United States.
Mobi offers a balance of oxygen delivery, weight and battery life for people who are on the go with chronic obstructive pulmonary disease (COPD) or other chronic diseases.
SAN DIEGO (December 4, 2018)—ResMed, a provider of cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, announced it has entered a definitive agreement to acquire Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma.
AMSTERDAM (November 12, 2018)—Royal Philips announced the launch of a global initiative to celebrate everyday wins by patients, providers and caretakers regarding the management of chronic obstructive pulmonary disease (COPD). Launching on World COPD Day November 21, this awareness and celebratory campaign aims to help inspire COPD patients and their caregivers around ways to improve their overall quality of life.
AMSTERDAM (October 30, 2018)—Royal Philips, a provider of health technology, announced the U.S. launch of InnoSpire Go, Philips’ smallest and lightest portable hand-held nebulizer system designed to deliver medication in just four minutes, reducing treatment time by up to 25 percent. The easy-to-use and virtually silent InnoSpire Go puts hospital-grade nebulizer technology into the hands of the user for portable, fast and effective medication delivery.
BALL GROUND, Ga. (August 21, 2018)—CAIRE Inc., manufacturers of oxygen therapy devices including the AirSep, SeQual and HELiOS brands, announced the official debut of the new portable oxygen concentrator, the FreeStyle Comfort, at their global manufacturing headquarters and respiratory Center of Excellence in Georgia this week.
SAN MATEO, Calif. (August 13, 2018)—Adherium, a digital health platform that focuses on improving medication adherence and patient outcomes, officially launched the Hailie solution in the United States, following its recent Food and Drug Administration (FDA) 510(k) over-the-counter clearance to enable sales direct to consumers.
LEHIGH VALLEY, Penn. (August 6, 2018)—Uni-flo2 Single-nasal Cannula System (Uni-flo2), a new patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, points to its benefits for COPD patients whose symptoms tend to worsen with the onset of seasonal allergies.
WATERLOO, Iowa (August 1, 2018)—Leitten Consulting released its latest findings addressing the cost shifts that occur when Medicare delays or fails to provide needed durable medical equipment and supplies to beneficiaries.
NEW YORK (February 12, 2018)—Jeremy Orr, MD, of University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation (NIV) in COPD.
ResMed is a provider of NIV devices for treating COPD (chronic obstructive pulmonary disease) in the home and hospital.
Dr. Orr’s $100,000 award will support his research focused on the impact of noninvasive ventilation on cardiovascular biomarkers in COPD.
SAN FRANCISCO (January 8, 2018)—ResMed today introduced Mobi, its first ResMed-branded portable oxygen concentrator (POC).
Mobi offers a balance of oxygen delivery, weight and battery life so that millions with chronic obstructive pulmonary disease (COPD) or other respiratory condition can enjoy ResMed-quality oxygen therapy at home or on the go.